Tenofovir As Prevention Of Hepatitis b Mother-to-child Transmission (TA-PROHM)
Sponsor: ANRS, Emerging Infectious Diseases
Listed as NCT02937779, this PHASE4 trial focuses on Hepatitis B Chronic Infection and Pregnancy and remains ongoing. Sponsored by ANRS, Emerging Infectious Diseases, it has been updated 12 times since 2017, reflecting substantial change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE4
Status: Unknown Status → Unknown
-
Nov 2021 — Jul 2024 [monthly]
Unknown Status PHASE4
Status: Active Not Recruiting → Unknown Status
-
Oct 2021 — Nov 2021 [monthly]
Active Not Recruiting PHASE4
-
Jan 2021 — Oct 2021 [monthly]
Active Not Recruiting PHASE4
▶ Show 7 earlier versions
-
Nov 2019 — Jan 2021 [monthly]
Active Not Recruiting PHASE4
Status: Recruiting → Active Not Recruiting
-
Jul 2019 — Nov 2019 [monthly]
Recruiting PHASE4
-
Jun 2018 — Jul 2019 [monthly]
Recruiting PHASE4
-
Dec 2017 — Jun 2018 [monthly]
Recruiting PHASE4
-
Oct 2017 — Dec 2017 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
Aug 2017 — Oct 2017 [monthly]
Not Yet Recruiting PHASE4
-
Jan 2017 — Aug 2017 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- ANRS, Emerging Infectious Diseases
For direct contact, visit the study record on ClinicalTrials.gov .